HORIZON PHARMA
Horizon Therapeutics operates as a biopharmaceutical company. It focuses on the development of prescription drugs for mild to moderate pain relief and arthritis. The company's product candidates include HZT-501, a proprietary fixed-dose combination formulation of NSAID and ibuprofen; and HZT-602, a combination oral drug product consisting of naproxen and famotidine. Horizon Therapeutics is based in Northbrook, Illinois, and was founded in 2005.
HORIZON PHARMA
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2005-01-01
Address:
Northbrook, Illinois, United States
Country:
United States
Website Url:
http://www.horizontherapeutics.com
Total Employee:
501+
Status:
Active
Contact:
+353 1 772 2100
Email Addresses:
[email protected]
Total Funding:
2.26 B USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail Amazon Virginia Region Gravity Forms Facebook Domain Verification MailChimp SPF Sendgrid
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Open Innovation Partners
Open Innovation Partners focuses on the development of cancer therapeutic agents.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Zavante Therapeutics
Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-05-08 | River Vision Development | River Vision Development acquired by Horizon Pharma | 145 M USD |
| 2016-09-12 | Raptor Pharmaceuticals | Raptor Pharmaceuticals acquired by Horizon Pharma | 800 M USD |
| 2015-03-30 | Hyperion Therapeutics | Hyperion Therapeutics acquired by Horizon Pharma | 1.1 B USD |
| 2014-03-19 | Vidara Therapeutics | Vidara Therapeutics acquired by Horizon Pharma | N/A |
| 2010-04-01 | Nitec Pharma AG | Nitec Pharma AG acquired by Horizon Pharma | N/A |
Investors List
Cowen and Company
Cowen and Company investment in Post-IPO Debt - Horizon Pharma
Deerfield
Deerfield investment in Post-IPO Debt - Horizon Pharma
Citigroup Global Markets
Citigroup Global Markets investment in Post-IPO Debt - Horizon Pharma
Pequot Capital
Pequot Capital investment in Series C - Horizon Pharma
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Series C - Horizon Pharma
Sutter Hill Ventures
Sutter Hill Ventures investment in Series C - Horizon Pharma
Sutter Hill Ventures
Sutter Hill Ventures investment in Series B - Horizon Pharma
Pequot Capital
Pequot Capital investment in Series B - Horizon Pharma
Scale Venture Partners
Scale Venture Partners investment in Series B - Horizon Pharma
Official Site Inspections
http://www.horizontherapeutics.com
- Host name: ec2-35-80-245-177.us-west-2.compute.amazonaws.com
- IP address: 35.80.245.177
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Horizon Pharma"
Horizon Therapeutics - Wikipedia
Horizon Therapeutics plc was a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and โฆSee details»
AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS โฆ
Oct 6, 2023 Advances Amgen's Mission to Serve Patients With First-in-Class Rare Disease Medicines. THOUSAND OAKS, Calif., Oct. 6, 2023 /PRNewswire/ -- Amgen (NASDAQ: โฆSee details»
Horizon Therapeutics Canada | Patient Support
If you would like to learn more about the services offered by TranscendRareโข, contact us: Call 1-844-380-7850 Monday to Friday 8am โ 8pm (EST) or; Email us at transcendrare@innomar โฆSee details»
Amgen | A Worldwide Pioneer in Biotechnology
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human โฆSee details»
Horizon Pharma - Crunchbase Company Profile & Funding
Horizon Therapeutics operates as a biopharmaceutical company. It focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.See details»
Horizon Therapeutics plc Announces Changes in Research and โฆ
Jan 24, 2020 DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced changes to its research and development organization structure.Effective โฆSee details»
Horizon Therapeutics - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Horizon Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Horizon Therapeutics Ltd - Company Profile - GlobalData
Website www.horizontherapeutics.com Telephone 353 1 7722100. No of Employees 2,190. Industry Pharmaceuticals and Healthcare. Revenue (2022) $3.6B Gain access to our ...See details»
Company Horizon Therapeutics Public Limited Company
May 31, 2009 Horizon Therapeutics plc is an Ireland-based global biotechnology company. The Company is focused on the discovery, development and commercialization of medicines that โฆSee details»
Horizon Therapeutics - Craft
Horizon Therapeutics $3.63 b in annual revenue in FY 2022. See insights on Horizon Therapeutics including office locations, competitors, revenue, financials, executives, โฆSee details»
Featured Employer | Horizon Therapeutics
Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. โฆSee details»
The Drug Company That Prospered Without Creating Any Drugs
Apr 13, 2023 An Injection of Marketing. To help sell its drugs, Horizon blankets specialist physicians with marketing and peer-to-peer appeals. Its payments to physicians for things like โฆSee details»
Horizon Therapeutics - Overview, News & Similar companies
Www.horizontherapeutics.ca. Revenue $9 Million. Industry Hospitals & Clinics Healthcare . Recent News & Media. No recent news or media. Overview; Who is Horizon Therapeutics. Horizon โฆSee details»
Horizon Therapeutics - 2025 Company Profile - Tracxn
Mar 9, 2025 Developer of drugs for treating rare and autoimmune diseases. The lead candidates of the company are UPLIZNA fucosylated IgG 1 kappa (IgG1ฮบ) monoclonal antibodies for โฆSee details»
Horizon Therapeutics plc Announces New Development
Sep 29, 2021 For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and โฆSee details»
Horizon Therapeutics Company Profile, Stock Price, News, โฆ
15 Best Large Workplaces in Chicago 2023 Employees say: "Horizon's employees are passionate about making a difference in the lives of patients. We are treated as valuable to the โฆSee details»
AGC Biologics and Horizon Therapeutics plc Expand Partnership
Oct 29, 2020 For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com. About AGC Biologics: AGC Biologics is a leading global โฆSee details»
Horizon Therapeutics Company Profile | Management and
SQL International Organization for Standardization . Other Vertical Industries Software (7 Technologies) Verifi Verisk Analytics . Clinical Pharmacology Emagia . ...See details»
horizon.wd1.myworkdayjobs.com
Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory โฆSee details»
Horizon Pharma in Canada - Pharmaceutical Companies Database
Address: Horizon Pharma Canada. 9131 Keele Street, Unit 4A Vaughan, ON L4K 0G7 Canada. Phone: +1 866-479-6742 Other Horizon Pharma's locations around the worldSee details»